RBX7455 Before Surgery for the Treatment of Operable Breast Cancer

Summary

This clinical trial studies the side effects and possible benefits of RBX7455 given before surgery in treating patients with breast cancer that can be removed by surgery (operable). RBX7455 contains live intestinal microbes (active drug), which are obtained from healthy human stool and may restore the normal balance of microorganisms in the intestines through the transplant of live and beneficial microorganisms.

Timeline

Start

2020-08-31

Primary completion

2023-01-11

Completion

2023-01-11

Outcome

Outcome not reported

Stopped (Enrollment): “poor accrual”

Drugs

Indications